Evedientes, Jilyn D.
HRN: 23-02-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2023
CEFUROXIME 500MG (TAB)
07/25/2023
08/01/2023
PO
500mg
BID X 7 Days
S/P NSVD With 2nd Degree RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes